Brain Health & Longevity

A brain health assessment is a structured evaluation of brain structure, vascular health and cognitive risk. At MBR Health, this may include 3T brain MRI, volumetric brain analysis, quantitative neuroimaging, brain angiography and specialist radiologist interpretation depending on the clinical question.

MBR Health provides imaging-led brain health assessment on the Gold Coast in Queensland. Assessment may include high-resolution 3T brain MRI, volumetric MRI analysis, brain vascular imaging and quantitative neuroimaging for patients seeking cognitive longevity, dementia risk assessment or neurological evaluation.

Volumetric brain MRI uses quantitative analysis to measure selected brain structures. This may include hippocampal volume, cortical grey matter, ventricular size and regional asymmetry. These measurements can help establish a baseline and monitor change over time.

Brain MRI can identify structural patterns that may be associated with dementia, including regional atrophy, vascular injury, white matter disease or other abnormalities. However, brain MRI does not diagnose every cause of dementia by itself. Diagnosis usually requires clinical assessment, cognitive testing and, in selected cases, molecular imaging or biomarker testing.

Brain MRI can show patterns that may support Alzheimer’s disease assessment, such as medial temporal or hippocampal atrophy. However, MRI cannot confirm Alzheimer’s disease by itself. Amyloid PET, tau PET, blood biomarkers, CSF testing and specialist neurological assessment may be required depending on the clinical situation.

NeuroQuant® is an FDA-cleared MRI post-processing tool that provides automated volumetric measurements of selected brain structures. It can help quantify brain volumes and support longitudinal monitoring, but it must be interpreted by clinicians in the context of symptoms, history and other findings.

SyMRI is a quantitative MRI platform that can generate measurements of tissue characteristics such as grey matter, white matter, cerebrospinal fluid and myelin-related parameters. In selected cases, these measurements may support assessment of demyelination, tissue integrity and neurological disease patterns.

Yes. Brain MRI does not use ionising radiation. MRI uses magnetic fields and radiofrequency pulses to generate images, making it different from CT. Some MRI examinations may use contrast depending on the clinical question, but many brain health and screening protocols can be performed without contrast.

Brain MRI can show previous silent infarcts, white matter disease and other structural changes relevant to vascular brain health. Brain angiography can assess selected blood vessels for aneurysm, narrowing or vascular malformation. This does not replace a full cardiovascular assessment, but it can provide important information in selected patients.

White matter disease refers to changes in the brain’s white matter, often related to small vessel disease, ageing, vascular risk factors, inflammation or other neurological conditions. The clinical significance depends on the extent, pattern, patient age, symptoms and risk factors.

No. A normal brain MRI can be reassuring, but it does not exclude every early neurodegenerative, molecular or functional process. Brain health is often best assessed through clinical context, imaging, cognitive testing, biomarkers where appropriate and longitudinal monitoring.

Some brain volume change can occur with ageing. The key question is whether the pattern, degree or rate of change is greater than expected for age and clinical context. Volumetric brain MRI can help provide objective measurements for comparison and follow-up.

Brain health imaging may be considered for patients with memory concerns, family history of dementia, vascular risk factors, neurological symptoms, prior abnormal imaging or proactive cognitive longevity goals. Suitability depends on clinical assessment and the question being asked.

No. Brain MRI and cognitive testing answer different questions. MRI assesses structure, volume and selected vascular or tissue findings. Cognitive testing assesses performance, memory, executive function and processing speed. Both may be useful depending on the clinical context.

The best brain scan for memory loss depends on the clinical question. A high-resolution brain MRI can assess structural change, vascular injury, atrophy, mass lesions and white matter disease. Volumetric analysis may add objective measurement of selected brain structures. In selected cases, PET imaging or biomarker testing may be required.

There is no universal interval for brain health monitoring. Follow-up depends on age, symptoms, risk factors, prior imaging findings, family history and the reason for assessment. In some patients, a baseline MRI may be enough. In others, longitudinal follow-up may be useful to assess change over time.

Yes. MBR Health offers the Executive Preventive Health Program for organisations looking to provide executive health screening for their leadership teams. The program uses precision, multi-modality whole-body imaging to screen for cancer, cardiac, metabolic, neurological and musculoskeletal conditions within a single, integrated pathway. Tailored group offerings are available for organisations. Please enquire directly to discuss your team’s requirements.